The electrophysiological footprint of CACNA1A disorders.

Epilepsy Episodic ataxia type 2 Familial hemiplegic migraine type 1 Intermittent epileptic discharges Spinocerebellar ataxia type 6 Voltage-gated calcium channels

Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 14 09 2020
accepted: 17 01 2021
revised: 16 01 2021
pubmed: 6 2 2021
medline: 24 6 2021
entrez: 5 2 2021
Statut: ppublish

Résumé

CACNA1A variants underlie three neurological disorders: familial hemiplegic migraine type 1 (FHM1), episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6). EEG is applied to study their episodic manifestations, but findings in the intervals did not gain attention up to date. We analyzed repeated EEG recordings performed between 1994 and 2019 in a large cohort of genetically confirmed CACNA1A patients. EEG findings were compared with those of CACNA1A-negative phenocopies. A review of the related literature was performed. 85 EEG recordings from 38 patients (19 EA2, 14 FHM1, 5 SCA6) were analyzed. Baseline EEG was abnormal in 55% of cases (12 EA2, 9 FHM1). The most common finding was a lateralized intermittent slowing, mainly affecting the temporal region. Slowing was more pronounced after a recent attack but was consistently detected in the majority of patients also during the follow-up. Interictal epileptic discharges (IEDs) were detected in eight patients (7 EA2,1 FHM1). EEG abnormalities and especially IEDs were significantly associated with younger age at examination (16 ± 9 vs 43 ± 21 years in those without epileptic changes, p = 0.003) and with earlier onset of disease (1 (1-2) vs 12 (5-45) years, p = 0.0009). EEG findings in CACNA1A-negative phenocopies (n = 15) were largely unremarkable (p = 0.03 in the comparison with CACNA1A patients). EEG abnormalities between attacks are highly prevalent in episodic CACNA1A disorders and especially associated with younger age at examination and earlier disease onset. Our findings underpin an age-dependent effect of CACNA1A variants, with a more severe impairment when P/Q channel dysfunction manifests early in life.

Identifiants

pubmed: 33544220
doi: 10.1007/s00415-021-10415-x
pii: 10.1007/s00415-021-10415-x
pmc: PMC8217028
doi:

Substances chimiques

CACNA1A protein, human 0
Calcium Channels 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2493-2505

Références

Rajakulendran S, Kaski D, Hanna MG (2012) Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS. Nat Rev Neurol 8(2):86–96
pubmed: 22249839
Epi KC (2016) De Novo Mutations in SLC1A2 and CACNA1A are important causes of epileptic encephalopathies. Am J Hum Genet 99(2):287–298
Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM et al (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87(3):543–552
pubmed: 8898206
Jen J, Kim GW, Baloh RW (2004) Clinical spectrum of episodic ataxia type 2. Neurology 62(1):17–22
pubmed: 14718690
Ducros A, Denier C, Joutel A, Cecillon M, Lescoat C, Vahedi K et al (2001) The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 345(1):17–24
pubmed: 11439943
Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, Amos C et al (1997) Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 15(1):62–69
pubmed: 8988170
Bavassano C, Eigentler A, Stanika R, Obermair GJ, Boesch S, Dechant G et al (2017) Bicistronic CACNA1A gene expression in neurons derived from spinocerebellar ataxia type 6 patient-induced pluripotent stem cells. Stem Cells Dev 26(22):1612–1625
pubmed: 28946818 pmcid: 5684673
Jen JC, Yue Q, Karrim J, Nelson SF, Baloh RW (1998) Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide responsive episodic ataxia. J Neurol Neurosurg Psychiatry 65(4):565–568
pubmed: 9771787 pmcid: 2170265
Kane N, Acharya J, Benickzy S, Caboclo L, Finnigan S, Kaplan PW et al (2017) A revised glossary of terms most commonly used by clinical electroencephalographers and updated proposal for the report format of the EEG findings. Revision 2017. Clin Neurophysiol Pract. 2:170–185
pubmed: 30214992 pmcid: 6123891
Indelicato E, Nachbauer W, Karner E, Eigentler A, Wagner M, Unterberger I et al (2019) The neuropsychiatric phenotype in CACNA1A mutations: a retrospective single center study and review of the literature. Eur J Neurol 26(1):66-e7
pubmed: 30063100
Nachbauer W, Nocker M, Karner E, Stankovic I, Unterberger I, Eigentler A et al (2014) Episodic ataxia type 2: phenotype characteristics of a novel CACNA1A mutation and review of the literature. J Neurol 261(5):983–91
pubmed: 24658662
Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE et al (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55(4):475–82
pubmed: 24730690
Beauvais K, Cave-Riant F, De Barace C, Tardieu M, Tournier-Lasserve E, Furby A (2004) New CACNA1A gene mutation in a case of familial hemiplegic migraine with status epilepticus. Eur Neurol 52(1):58–61
pubmed: 15240985
Chan YC, Burgunder JM, Wilder-Smith E, Chew SE, Lam-Mok-Sing KM, Sharma V et al (2008) Electroencephalographic changes and seizures in familial hemiplegic migraine patients with the CACNA1A gene S218L mutation. J Clin Neurosci 15(8):891–4
pubmed: 18313928
de Vries B, Stam AH, Beker F, van den Maagdenberg AM, Vanmolkot KR, Laan L et al (2008) CACNA1A mutation linking hemiplegic migraine and alternating hemiplegia of childhood. Cephalalgia 28(8):887–91
pubmed: 18498393
Debiais S, Hommet C, Bonnaud I, Barthez MA, Rimbaux S, Riant F et al (2009) The FHM1 mutation S218L: a severe clinical phenotype? A case report and review of the literature. Cephalalgia 29(12):1337–9
pubmed: 19438926
Garcia Segarra N, Gautschi I, Mittaz-Crettol L, Kallay Zetchi C, Al-Qusairi L, Van Bemmelen MX et al (2014) Congenital ataxia and hemiplegic migraine with cerebral edema associated with a novel gain of function mutation in the calcium channel CACNA1A. J Neurol Sci 342(1–2):69–78
pubmed: 24836863
Ohmura K, Suzuki Y, Saito Y, Wada T, Goto M, Seto S (2012) Sporadic hemiplegic migraine presenting as acute encephalopathy. Brain Dev 34(8):691–5
pubmed: 22136990
Stam AH, Luijckx GJ, Poll-The BT, Ginjaar IB, Frants RR, Haan J et al (2009) Early seizures and cerebral oedema after trivial head trauma associated with the CACNA1A S218L mutation. J Neurol Neurosurg Psychiatry 80(10):1125–9
pubmed: 19520699
Tantsis EM, Gill D, Griffiths L, Gupta S, Lawson J, Maksemous N et al (2016) Eye movement disorders are an early manifestation of CACNA1A mutations in children. Dev Med Child Neurol 58(6):639–44
pubmed: 26814174
Topakian R, Pischinger B, Stieglbauer K, Pichler R (2014) Rare clinical findings in a patient with sporadic hemiplegic migraine: FDG-PET provides diminished brain metabolism at 10-year follow-up. Cephalalgia 34(5):392–6
pubmed: 24270521
Vahedi K, Denier C, Ducros A, Bousson V, Levy C, Chabriat H et al (2000) CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy. Neurology 55(7):1040–2
pubmed: 11061267
Kors EE, Haan J, Giffin NJ, Pazdera L, Schnittger C, Lennox GG et al (2003) Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation: a description of 5 families with familial hemiplegic migraine. Arch Neurol 60(5):684–8
pubmed: 12756131
Kors EE, Melberg A, Vanmolkot KR, Kumlien E, Haan J, Raininko R et al (2004) Childhood epilepsy, familial hemiplegic migraine, cerebellar ataxia, and a new CACNA1A mutation. Neurology 63(6):1136–7
pubmed: 15452324
Blumkin L, Michelson M, Leshinsky-Silver E, Kivity S, Lev D, Lerman-Sagie T (2010) Congenital ataxia, mental retardation, and dyskinesia associated with a novel CACNA1A mutation. J Child Neurol 25(7):892–7
pubmed: 20097664
Liguori C, Albanese M, Sancesario G, Stefani A, Marciani MG, Pierantozzi M (2013) May a suspicious psychiatric disorder hide sporadic hemiplegic migraine? Genetic test as prompting factor for diagnosis. Neurol Sci 34(10):1845–6
pubmed: 23397224
Sanchez-Albisua I, Schoning M, Jurkat-Rott K, Lerche H (2013) Possible effect of corticoids on hemiplegic attacks in severe hemiplegic migraine. Pediatr Neurol 49(4):286–8
pubmed: 23831250
Riant F, Ducros A, Ploton C, Barbance C, Depienne C, Tournier-Lasserve E (2010) De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine. Neurology 75(11):967–72
pubmed: 20837964
Kors EE, Terwindt GM, Vermeulen FL, Fitzsimons RB, Jardine PE, Heywood P et al (2001) Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann Neurol 49(6):753–60
pubmed: 11409427
Stam AH, Vanmolkot KR, Kremer HP, Gartner J, Brown J, Leshinsky-Silver E et al (2008) CACNA1A R1347Q: a frequent recurrent mutation in hemiplegic migraine. Clin Genet 74(5):481–5
pubmed: 18400034
Carreno O, Garcia-Silva MT, Garcia-Campos O, Martinez-de Aragon A, Cormand B, Macaya A (2011) Acute striatal necrosis in hemiplegic migraine with de novo CACNA1A mutation. Headache 51(10):1542–6
pubmed: 22082423
Malpas TJ, Riant F, Tournier-Lasserve E, Vahedi K, Neville BG (2010) Sporadic hemiplegic migraine and delayed cerebral oedema after minor head trauma: a novel de novo CACNA1A gene mutation. Dev Med Child Neurol 52(1):103–4
pubmed: 19811514
Zangaladze A, Asadi-Pooya AA, Ashkenazi A, Sperling MR (2010) Sporadic hemiplegic migraine and epilepsy associated with CACNA1A gene mutation. Epilepsy Behav 17(2):293–5
pubmed: 20071244
Yamazaki S, Ikeno K, Abe T, Tohyama J, Adachi Y (2011) Hemiconvulsion-hemiplegia-epilepsy syndrome associated with CACNA1A S218L mutation. Pediatr Neurol 45(3):193–6
pubmed: 21824570
Romaniello R, Zucca C, Tonelli A, Bonato S, Baschirotto C, Zanotta N et al (2010) A wide spectrum of clinical, neurophysiological and neuroradiological abnormalities in a family with a novel CACNA1A mutation. J Neurol Neurosurg Psychiatry 81(8):840–3
pubmed: 20682717
Damaj L, Lupien-Meilleur A, Lortie A, Riou E, Ospina LH, Gagnon L et al (2015) CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms. Eur J Hum Genet 23(11):1505–12
pubmed: 25735478 pmcid: 4613477
Imbrici P, Jaffe SL, Eunson LH, Davies NP, Herd C, Robertson R et al (2004) Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain 127(Pt 12):2682–92
pubmed: 15483044
Jouvenceau A, Eunson LH, Spauschus A, Ramesh V, Zuberi SM, Kullmann DM et al (2001) Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 358(9284):801–7
pubmed: 11564488
Jung J, Testard H, Tournier-Lasserve E, Riant F, Vallet AE, Berroir S et al (2010) Phenotypic variability of episodic ataxia type 2 mutations: a family study. Eur Neurol 64(2):114–6
pubmed: 20639635
Labrum RW, Rajakulendran S, Graves TD, Eunson LH, Bevan R, Sweeney MG et al (2009) Large scale calcium channel gene rearrangements in episodic ataxia and hemiplegic migraine: implications for diagnostic testing. J Med Genet 46(11):786–91
pubmed: 19586927
Rajakulendran S, Graves TD, Labrum RW, Kotzadimitriou D, Eunson L, Davis MB et al (2010) Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy. J Physiol 588(Pt 11):1905–13
pubmed: 20156848 pmcid: 2901979
Kaido M, Furuta M, Nakamori M, Yuasa Y, Takahashi MP (2016) Episodic ataxia type 2 manifests as epileptiform electroencephalographic activity with no epileptic attacks in two family members. Rinsho Shinkeigaku 56(4):260–4
pubmed: 27025991
Yugrakh MS, Levy OA (2012) Clinical reasoning: a middle-aged man with episodes of gait imbalance and a newly found genetic mutation. Neurology 79(16):e135-9
pubmed: 23071170 pmcid: 3468775
Choi JH, Seo JD, Choi YR, Kim MJ, Shin JH, Kim JS et al (2015) Exercise-induced downbeat nystagmus in a Korean family with a nonsense mutation in CACNA1A. Neurol Sci 36(8):1393–6
pubmed: 25784583
Choi KD, Yook JW, Kim MJ, Kim HS, Park YE, Kim JS et al (2013) Possible anticipation associated with a novel splice site mutation in episodic ataxia type 2. Neurol Sci 34(9):1629–32
pubmed: 23344743
Imbrici P, Eunson LH, Graves TD, Bhatia KP, Wadia NH, Kullmann DM et al (2005) Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A. Neurology 65(6):944–6
pubmed: 16186543
Kaunisto MA, Harno H, Kallela M, Somer H, Sallinen R, Hamalainen E et al (2004) Novel splice site CACNA1A mutation causing episodic ataxia type 2. Neurogenetics 5(1):69–73
pubmed: 14530926
Mantuano E, Romano S, Veneziano L, Gellera C, Castellotti B, Caimi S et al (2010) Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2. J Neurol Sci 291(1–2):30–6
pubmed: 20129625
Riant F, Lescoat C, Vahedi K, Kaphan E, Toutain A, Soisson T et al (2010) Identification of CACNA1A large deletions in four patients with episodic ataxia. Neurogenetics 11(1):101–6
pubmed: 19633872
Strupp M, Kalla R, Dichgans M, Freilinger T, Glasauer S, Brandt T (2004) Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology 62(9):1623–5
pubmed: 15136697
Stendel C, D'Adamo MC, Wiessner M, Dusl M, Cenciarini M, Belia S, et al. Association of A Novel Splice Site Mutation in P/Q-Type Calcium Channels with Childhood Epilepsy and Late-Onset Slowly Progressive Non-Episodic Cerebellar Ataxia. Int J Mol Sci. 2020;21(11).
Baloh RW, Yue Q, Furman JM, Nelson SF (1997) Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p. Ann Neurol 41(1):8–16
pubmed: 9005860
Cuenca-Leon E, Banchs I, Serra SA, Latorre P, Fernandez-Castillo N, Corominas R et al (2009) Late-onset episodic ataxia type 2 associated with a novel loss-of-function mutation in the CACNA1A gene. J Neurol Sci 280(1–2):10–4
pubmed: 19232643
Du X, Chen Y, Zhao Y, Luo W, Cen Z, Hao W (2017) Dramatic response to pyridoxine in a girl with absence epilepsy with ataxia caused by a de novo CACNA1A mutation. Seizure 45:189–91
pubmed: 28088730
Nardello R, Plicato G, Mangano GD, Gennaro E, Mangano S, Brighina F et al (2020) Two distinct phenotypes, hemiplegic migraine and episodic Ataxia type 2, caused by a novel common CACNA1A variant. BMC Neurol 20(1):155
pubmed: 32336275 pmcid: 7183684
Neufeld MY, Nisipeanu P, Chistik V, Korczyn AD (1996) The electroencephalogram in acetazolamide-responsive periodic ataxia. Mov Disord 11(3):283–8
pubmed: 8723146
Russell MB, Ducros A (2011) Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol 10(5):457–70
pubmed: 21458376
Djamshidian A, Grassl R, Seltenhammer M, Czech T, Baumgartner C, Schmidbauer M et al (2002) Altered expression of voltage-dependent calcium channel alpha(1) subunits in temporal lobe epilepsy with Ammon’s horn sclerosis. Neuroscience 111(1):57–69
pubmed: 11955712
Xu JH, Tang FR. Voltage-dependent calcium channels, calcium binding proteins, and their interaction in the pathological process of epilepsy. Int J Mol Sci. 2018;19(9).
Hell JW, Westenbroek RE, Warner C, Ahlijanian MK, Prystay W, Gilbert MM et al (1993) Identification and differential subcellular localization of the neuronal class C and class D L-type calcium channel alpha 1 subunits. J Cell Biol 123(4):949–62
pubmed: 8227151
Llinas RR, Choi S, Urbano FJ, Shin HS (2007) Gamma-band deficiency and abnormal thalamocortical activity in P/Q-type channel mutant mice. Proc Natl Acad Sci USA 104(45):17819–24
pubmed: 17968008 pmcid: 2077027
Pedroarena C, Llinas R (1997) Dendritic calcium conductances generate high-frequency oscillation in thalamocortical neurons. Proc Natl Acad Sci USA 94(2):724–8
pubmed: 9012852 pmcid: 19581

Auteurs

Elisabetta Indelicato (E)

Center for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Iris Unterberger (I)

Epileptology Division, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Wolfgang Nachbauer (W)

Center for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Andreas Eigentler (A)

Center for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Matthias Amprosi (M)

Center for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.

Fiona Zeiner (F)

Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.

Edda Haberlandt (E)

Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Department of Pediatrics, City Hospital, Dornbirn, Austria.

Manuela Kaml (M)

Epileptology Division, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Elke Gizewski (E)

Department of Neuroradiology, Medical University of Innsbruck, Innsbruck, Austria.

Sylvia Boesch (S)

Center for Rare Movement Disorders Innsbruck, Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria. sylvia.boesch@i-med.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH